Related Experiment Video
Updated: Jul 16, 2026
09:52
Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)
Published on: April 19, 2013
Genetic contributions to type 2 diabetes: recent insights
Michèle M Sale1, Stephen S Rich
1Internal Medicine, Wake Forest University School of Medicine, Center for Human Genomics, Medical Center Blvd, Winston-Salem, NC 27157, USA. msale@wfubmc.edu
Expert Review of Molecular Diagnostics
|March 3, 2007
Summary
Recent research highlights novel genetic associations for Type 2 diabetes, including transcription factor 7-like 2 and micro-opioid receptor genes. These findings offer new insights into diabetes susceptibility and potential therapeutic targets.
Area of Science:
- Genetics and genomics
- Endocrinology
- Metabolic diseases
Background:
- Type 2 diabetes (T2D) genetic loci require confirmation across diverse populations.
- Established T2D risk genes include calpain 10, PPAR-gamma, Kir6.2, HNF4α, and TCF1.
Purpose of the Study:
- To review recent (12-month) novel genetic associations for Type 2 diabetes.
- To explore potential mechanisms and therapeutic targets for T2D.
Main Methods:
- Literature review of recent genetic association studies for T2D.
- Focus on transcription factor 7-like 2 (TCF7L2), micro-opioid receptor (MOR), and suppressor of cytokine signaling 2 (SOCS2) genes.
- Analysis of adipokines vaspin and retinol binding protein 4 (RBP4) expression and function.
Main Results:
- Recent studies report novel associations between T2D and TCF7L2, MOR, and SOCS2.
- Expression and functional analyses of vaspin and RBP4 provide insights into adipokine roles in T2D.
- Identified loci contribute to understanding T2D pathogenesis.
Conclusions:
- Novel genetic associations, including TCF7L2, offer new perspectives on T2D susceptibility.
- Adipokine research (vaspin, RBP4) deepens understanding of metabolic regulation.
- These findings may lead to improved diagnostic and therapeutic strategies for Type 2 diabetes.
Related Concept Videos
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...